NASDAQ: INMInmed Pharmaceuticals Inc Stock Ownership - Who owns Inmed Pharmaceuticals?
Insider buying vs selling
Have Inmed Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when INM insiders and whales buy or sell their stock.
INM Shareholders
What type of owners hold Inmed Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Shane Aaron Johnson | 48.30% | 583,023 | $1.35M | Insider |
| Eric A. Adams | 3.64% | 43,959 | $101.98k | Insider |
| Andrew Hull | 3.17% | 38,258 | $88.76k | Insider |
| Bruce Colwill | 0.95% | 11,515 | $26.71k | Insider |
| Ubs Group Ag | 0.64% | 7,762 | $18.01k | Institution |
| Tower Research Capital LLC Trc | 0.03% | 400 | $928.00 | Institution |
| Sbi Securities Co Ltd | 0.02% | 300 | $696.00 | Institution |
| Banque Cantonale Vaudoise | 0.00% | 6 | $13.92 | Institution |
| Federation Des Caisses Desjardins Du Quebec | 0.00% | 1 | $2.32 | Institution |
| Bessemer Group Inc | 0.00% | 1 | $2.32 | Institution |
INM vs Biotech Stocks
Inmed Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.